Luvu Brands (OTCQB: LUVU) Reports Fiscal 2026 Results: 5.8% Revenue Growth, Gross Margin Expansion to 31.5%, Positive Operating Income, and Adjusted EBITDA…

Luvu Brands, Inc. (LUVU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 FOR IMMEDIATE RELEASE Luvu Brands (OTCQB: LUVU) Reports Fiscal 2026 Results: 5.8% Revenue Growth, Gross Margin Expansion to 31.5%, Positive Operating Income, and Adjusted EBITDA More Than Tripled to $1.3 Million Vertically integrated “Made in USA” manufacturer of the

Event · Earnings
Original reporting
Published Sep 29, 2026, 5:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 5:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$LUVU
Bullish
high confidence
Mentioned
$LUVU
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$LUVUBullishMed
01

Why it matters

The earnings release provides fresh financial metrics that were not public before the filing, indicating a turnaround.

02

Market read

First‑report earnings for a micro‑cap; modest upside potential but limited market breadth.

03

What to watch

Higher fuel and freight costs from Middle‑East conflict could pressure margins going forward.

Relevance 7/10Novelty 7/10Timing: after-hours

Background

Luvu Brands is an OTC‑QB listed designer and manufacturer of consumer lifestyle products.

Company-level read

Ticker impact

$LUVUBullishHigh confidence
Context

Luvu Brands reported FY2026 results with revenue up 5.8%, gross margin expansion to 31.5%, positive operating income and adjusted EBITDA more than tripled.

Expected impact

likely modest upside as market prices in improved earnings and cash flow

Evidence & confidence

First‑report earnings release shows revenue growth, margin expansion and a swing to operating profit, which typically supports a price gain for a micro‑cap.

Market effects

Shows strength in consumer lifestyle and wellness niche, may boost peer small‑cap manufacturers.

Limited to US OTC market; no broader regional effect.

Minimal global impact due to small size.

Counterpoint

Despite earnings beat, the company remains loss‑making and cash‑light; investors may stay cautious.

Key entities

  • Louis Friedman

    Founder and CEO who commented on the FY2026 performance.

  • Christopher Knauf

    Chief Financial Officer who provided financial commentary.

Related articles

$LUVUMed

Luvu Brands, Inc.: Luvu Brands Reports First Quarter Fiscal 2027 Results: 10% Net Sales Growth, Wholesale Sales Up 12%

Luvu Brands (LUVU) reported Q1 FY2027 results with net sales up 10% to $6.78M, wholesale sales up 12.3% to $4.72M, and direct-to-consumer sales up 5.3% to $2.06M. Gross profit fell 10.1% to $1.78M due to higher freight and labor costs, resulting in an operating loss of $332K and a net loss of $365K. Cash from operations increased to $120K, and cash reserves were $1.02M.

$LUVUMed

Luvu Brands (OTCQB: LUVU) Reports First Quarter Fiscal 2027 Results: 10% Net Sales Growth, Wholesale Sales Up 12%

Luvu Brands, Inc. (LUVU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 FOR IMMEDIATE RELEASE Luvu Brands (OTCQB: LUVU) Reports First Quarter Fiscal 2027 Results: 10% Net Sales Growth, Wholesale Sales Up 12% Vertically integrated “Made in USA” manufacturer of the Liberator, Jaxx, and Avana product lines grows net sales to $6.8 million; o

$XPMedAI 8/10

XP Q3 2026 slides: asset growth strong, but margin pressure evident

XP Inc. reported Q3 2026 earnings with total client assets up 15% YoY to R$2.2T, but net margins contracted to 26.9%. Revenue grew 8% YoY to R$5.3B, while SG&A expenses rose 12% YoY. Shares fell 4.26% post-earnings. The company is diversifying revenue, with non-investment revenues now 20% of retail revenue. Management expects 10% annual top-line growth in 2027.